This report contains results of studies designed to determine whether quinine has direct effects on myofilament Ca 2ϩ sensitization in addition to effects on Ca 2ϩ . Quinine decreased the EC 50 value and maximal contraction of intact arterial strips to histamine. Incubation of arterial strips with indomethacin or 1H-[1,2,4]oxadiazole[4,3-␣]quinoxalin-1-one did not alter quinine inhibition, suggesting that the effect is not mediated via cyclooxygenase or cGMP. Pretreatment of strips with quinine had no effect on the histamine-dependent increases in myosin light chain phosphorylation levels. Quinine inhibited Ca 2ϩ -induced contraction in ␣-toxin permeabilized strips, but not the Ca 2ϩ -induced contraction in Triton X-100 permeabilized strips. Pretreatment of the ␣-toxin permeabilized strips with quinine before stimulation with guanosine-5Ј-O-(3-thio)triphosphate (GTP␥S) did not have any effect on the response. In conclusion, quinine inhibited Ca 2ϩ -dependent contractions of the ␣-toxin permeabilized strips, which retain modulatory pathways both upstream and downstream from the contractile proteins but did not inhibit GTP␥S-dependent contraction of the ␣-toxin permeabilized preparation important in upstream modulation of the contraction. Moreover, quinine did not inhibit the Ca 2ϩ -dependent contractions of the Triton X-100 permeabilized strips, which are devoid of all modulatory pathways. This suggests that quinine does not act upstream from or directly on the contractile proteins. A more likely site of action may be downstream of the contractile proteins and specifically at the coupling of the contractile proteins with the physiological endpoint of force development.
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Quinine and its stereoisomer quinidine are two alkaloids derived from cinchona bark. Quinine is less potent and less toxic compared with quinidine and has been used as an antimalarial drug for more than a century, whereas quinidine is preferred for the treatment of cardiac arrhythmias (Salata and Wasserstrom, 1988) . Both drugs have long been known to produce vasodilation, an increase in renal blood flow, and a decrease in blood pressure in dogs with experimental neurogenic hypertension (Hiatt, 1948) . In addition, parenteral administration of therapeutic doses of quinidine and quinine caused forearm vasodilation and decreased mean arterial pressure in humans Mariano et al., 1992) . These vasodilatory effects of quinine have been suggested to be due to actions on the adrenergic innervation of vascular smooth muscle as well as direct effects on the vascular smooth muscle cell. In rat cardiac membranes, human platelets, and rat kidney cells, quinidine is a competitive antagonist of ␣ 1 -and ␣ 2 -receptors (Motulsky et al., 1984) . However, the observation that quinidine-induced vasodilation persisted even in denervated limbs suggested that a nonadrenergic effect may also be involved Schmid et al., 1974) .
Quinidine and quinine inhibit KCl-induced contractions in rat and rabbit aorta (Cook et al., 1987) and rat rectum (Del Pozo et al., 1996) as well as angiotensin II-stimulated contractions in rabbit aorta (Cook et al., 1987) . These compounds also inhibit KCl-induced 45 Ca uptake in A7r5 cells (Cook and Quast, 1990) and shift the CaCl 2 -force response to the right in depolarized guinea pig taenia coli (Spedding and Berg, 1985) . Taken together, these findings suggest that quinine inhibits calcium influx through voltage-dependent calcium channels in smooth muscle. Quinine's effects also seem to be at the level of intracellular calcium handling. Quinine has been shown to inhibit calcium release from internal stores of brain microsomes and macrophages (Lee and Go, 1996; Misra et al., 1997) . More to the point of this present study, quinine reduced 5-hydroxytryptamine-induced contractions of rat aorta smooth muscle in calcium-free medium (Del Pozo et al., 1996) .
In addition to effects on divalent cations, quinine inhibits monovalent conductances in membranes of a variety of different cell types (Walden and Speckmann, 1981; Salata and Wasserstrom, 1988) . Using smooth muscle as the experimen-tal model, quinine has been described as a potassium current blocker. For example, quinine has been shown to inhibit both the K v1.5 (Overturf et al., 1994) and K v2.2 (Schmalz et al., 1998) currents in vascular smooth muscle. It is difficult, however, to understand how inhibition of an outward potassium current could account for inhibition of a vascular response. A more likely response to inhibition of rectifying potassium currents would be an augmentation or at least prolongation of the contraction (Jackson, 2000) .
It is clear that quinine and its isomer quinidine inhibit contraction of vascular smooth muscle by multiple pathways. The pathways proposed to date have suggested membrane receptor and calcium handling as sites of action. However, to our knowledge, no studies have shown whether quinine has effects directly at the level of activation/modulation of the contractile apparatus in vascular smooth muscle. After a stimulus-induced increase in calcium, contraction of vascular smooth muscle is initiated by phosphorylation of the 20-kDa myosin light chain (MLC). This phosphorylation step is catalyzed by the calcium-and calmodulin-dependent MLC kinase (Kamm and Stull, 1985) . Relaxation follows dephosphorylation of the MLC by a MLC phosphatase. In addition to the direct regulation of the contractile proteins by the MLC kinase/phosphatase system, the sensitivity of the proteins to calcium can be modulated by a receptor and G protein-dependent pathway (Somlyo and Somlyo, 1994) . Therefore, the goal of this study was to determine whether quinine inhibits vascular smooth muscle of the swine carotid artery and if so, is the inhibition solely due to effects on calcium or are steps in the activation or modulation of the contractile proteins also involved. The specific hypothesis tested was that quinine-induced inhibition is not mediated by changes in the level of activator calcium or events upstream from the contractile proteins. If this is correct then it will lend support to the secondary hypothesis that quinine-induced inhibition involves components downstream from the contractile proteins important in mechanotransduction such as paxillin or talin.
Materials and Methods
Intact and Permeabilized Tissue Preparation. Swine carotid arteries were obtained from a local slaughterhouse and transported to the laboratory in an ice-cold MOPS-buffered physiological salt solution. Arteries were cleaned of connective tissue and then dissected free of both intima and adventitia, leaving a thin medial layer for experimentation. Intact medial strips of swine carotid artery (7 ϫ 0.7 mm) were suspended between a Grass FT.03 force transducer and a stationary clip in water-jacketed organ baths. The strips were equilibrated in physiological salt solution at 37°C, pH 7.4, and bubbled with 100% O 2 for 90 to 120 min. A passive force of 3 g was applied to all tissues. This passive force sets the muscle at a length that approximates L o . During the equilibration period, tissues were maximally contracted with 30 M histamine for 5 min at 45-min intervals. For experiments involving permeabilized tissues, medial strips (200 ϫ 700 m) were mounted in a Muscle Research Station (Scientific Instruments, Heidelberg, Germany) at room temperature and allowed to equilibrate for 90 min under a passive tension of 100 mg. The tissues were contracted with 30 M histamine every 45 min until a reproducible contraction was attained, followed by incubation in relaxing solution composed of 100 mM K-acetate, 5 mM EGTA, 5 mM MgCl 2 , 5 mM Na 2 ATP, 20 mM creatine phosphate, 20 mM imidazole, pH 7.0, and 0.5 mM DTT, for 30 min. Tissues were then permeabilized by exposure to either 850 U/ml Staphylococcus aureus ␣-toxin for 30 min or 0.2% Triton X-100 for 18 min. Solutions for the permeabilized tissue studies contained 20 mM imidazole, pH 7.0, 1 mM Mg 2ϩ , 5 mM ATP, 5 mM EGTA, sufficient K-acetate to maintain ionic strength at 120 mM, and levels of free Ca 2ϩ appropriate for the particular experimental design. In addition, all solutions used with ␣-toxin permeabilized tissues contained 1 M ionomycin and 5 mM creatine phosphate, and all solutions used with Triton X-100 permeabilized fibers contained 0.5 M calmodulin.
Determination of Myosin Light Chain Phosphorylation Levels. Muscle tissues that were used for determination of myosin light chain phosphorylation levels were treated identically to those used for force measurement. The tissues were rapidly frozen, at rest or after stimulation in an acetone/dry ice slurry containing 6% trichloroacetic acid and 10 mM DTT. The tissues were slowly brought to room temperature and rinsed in acetone containing 10 mM DTT. The tissues were then air dried, weighed, and homogenized on ice in a solution containing 6 M urea, 50 mM Tris pH 6.8, 10 mM DTT, 10 mM EGTA, 5 mM EDTA, and 5 mM NaF. Homogenized samples were assayed for total protein using the Bradford technique. Five micrograms of protein from each sample was then subjected to twodimensional gel electrophoresis followed by transfer to nitrocellulose membrane as described previously (Moreland et al., 1992) . Proteins were visualized using colloidal gold (Amersham Biosciences, Piscataway, NJ). MLC phosphorylation levels were quantified by densitometric analysis of optically scanned images. Phosphorylation levels were calculated by determining the volume of phosphorylated MLC as a percentage of the volume of both phosphorylated and unphosphorylated MLC.
Chemicals. Quinine, indomethacin, 1H-[1,2,4]oxadiazole[4,3-␣]quinoxalin-1-one (ODQ), ATP, and histamine were obtained from Sigma-Aldrich (St. Louis, MO). Ionomycin and GTP␥S were purchased from Calbiochem (La Jolla, CA). S. aureus ␣-toxin was obtained from List Biological Laboratory (Campbell, CA).
Statistics. All results are expressed as the means Ϯ S.E.M. with n representing the number of observations. Data were compared for statistical significance using the Student's t test (paired and unpaired). Probability level Ͻ0.05 was taken as statistically significant.
Results
Quinine Inhibition of Histamine-Induced Contraction. The first set of experiments was designed to determine whether quinine inhibited intact strips of swine carotid artery in a concentration-dependent manner. The strips were subjected to the cumulative addition of histamine (0.1-100 M) after which they were rinsed and allowed to fully relax. The strips were then incubated in varying concentrations of quinine (100 -400 M) and then subjected again to the cumulative addition of histamine. Data were normalized to the force generated in response to a single contraction of 10 M histamine before the initiation of the cumulative concentration-response curves. As shown in Fig. 1 , incubation of the vascular strips with different concentrations of quinine induced a concentration-dependent inhibition of the contractile response to histamine. Increasing quinine concentration produced concentration-dependent depression of the maximal histamine-stimulated force generation. Quinine also decreased the sensitivity of the strips to histamine as evidenced by a significant increase in the EC 50 value (control, 2.8 Ϯ 0.3 M; 100 M quinine, 3.0 Ϯ 0.6 M; 200 M quinine, 4.2 Ϯ 0.7 M; and 400 M quinine, 6.6 Ϯ 0.7 M). Time controls were performed to ensure consistency of histamine concentration-response curves over the same time frame as the quinine inhibition experiments (data not shown).
The reduction in histamine-induced force in the presence of quinine could be due to a decrease in activator calcium levels, Fig. 2 suggest that quinine does not involve active relaxation pathways, at least not two of the major pathways known to be important in vascular smooth muscle. Incubation of the vascular strips in 1 M indomethacin to inhibit the prostaglandin synthetic pathway had no effect on the control histamine concentration-response relationship nor the inhibitory actions of 300 M quinine ( Fig. 2A) . Similarly, 10 M ODQ, an inhibitor of the cyclic GMP-dependent protein kinase pathway, had no effect on the vascular responsiveness to histamine nor the inhibition induced by 300 M quinine (Fig. 2B) . Control experiments were performed to test the effectiveness of ODQ in inhibiting the cGMP-dependent relaxation in the swine carotid arteries. ODQ (10 M) completely blocked the sodium nitroprusside (0.1-1.0 mM)-induced relaxation of the swine carotid arterial strips. Sodium nitroprusside produced a 65% relaxation in the absence of ODQ and a 0% relaxation in the presence of ODQ (n ϭ 4). Baseline force values were unaffected by either ODQ or indomethacin.
Effect of Quinine on Myosin Light Chain Phosphorylation. The primary step involved in activation of smooth muscle contraction is the calcium-and calmodulin-dependent phosphorylation of the 20-kDa myosin light chain (Kamm and Stull, 1985) . Therefore, inhibition of myosin light chain phosphorylation is a logical site of action for the quinineinduced reduction in contraction. Moreover, although a precise relationship does not exist between calcium and myosin light chain phosphorylation, in most cases myosin light chain phosphorylation levels follow a directional change in calcium concentration. Thus, we measured histamine-induced levels of myosin light chain phosphorylation in the presence and absence of quinine, and the results are shown in Fig. 3 . The data in Fig. 3 demonstrate that neither 300 M quinine (open symbols) nor 600 M quinine (inserted column) have any effect on basal or peak (1 min) histamine-induced increases in myosin light chain phosphorylation. The time-course data shown in Fig. 3 indicate that 300 M quinine does produce a small but significant depression in myosin light chain phosphorylation levels after 10 min of histamine stimulation, suggesting that steady-state calcium levels may be decreased or MLC phosphatase activity may be increased. However, even taking into account the potential for cooperativity (Butler and Siegman, 1998) , this small albeit significant decrease in myosin light chain phosphorylation is not consistent with the nearly 60% decrease in force shown in Fig. 1 .
Effect of Quinine on Ca 2؉ -Induced Contraction of Permeabilized Vascular Tissue. To directly test the hypothesis that quinine inhibits vascular contractile activation directly rather than indirectly through actions in calcium metabolism, we used the S. aureus ␣-toxin permeabilized preparation. This preparation allows control of the intracellular environment while maintaining physiologically relevant signaling pathways intact. The permeabilized strips were subjected to the cumulative addition of Ca 2ϩ (0.3-3 M) in the absence and presence of 300 M quinine; the results are shown in Fig. 4 . Even in conditions of constant free calcium (5 mM EGTA and 10 M ionomycin), quinine produced significant decreases in force development at every [Ca 2ϩ ]. Smooth muscle is known to be modulated by receptordependent pathways upstream from the contractile filaments. To determine whether quinine is acting at the level of receptor-mediated, G protein-dependent pathways, we contracted the ␣-toxin permeabilized strips with Ca 2ϩ plus GTP␥S in the absence and presence of 300 M quinine (Fig.  5) . Quinine had no effect on the GTP␥S-dependent increase in force development, suggesting receptor and G proteinmediated effects are not involved.
Quinine inhibited the direct calcium-dependent contraction in the ␣-toxin permeabilized strips but not the receptor and G protein-mediated events, thus we were interested in determining whether the inhibitory actions of quinine are at the level of the contractile proteins. To address this question, we used the Triton X-100 permeabilized preparation. The Triton X-100 permeabilized preparation provides direct access to the contractile filaments but is devoid of all modulatory signaling pathways. Triton X-100 permeabilized strips, and for comparison ␣-toxin permeabilized strips, were subjected to contraction by 0.5 M Ca 2ϩ . As can be seen in Fig.  6 , 300 M quinine inhibited the Ca 2ϩ -dependent response of the ␣-toxin permeabilized strips but had no effect on the contraction of the Triton X-100 permeabilized strips. Because quinine inhibited Ca 2ϩ -dependent contraction of the ␣-toxin permeabilized preparation that retains all modulatory pathways both upstream and downstream from the contractile proteins but did not inhibit the GTP␥S-induced contraction important in upstream regulation, the actions of quinine may not be at the level of the contractile filaments per se but possibly downstream from the actin-myosin interactions. This suggestion is supported by the finding that quinine had no effect on the Triton X-100 detergent skinned preparation, which is devoid of all modulatory pathways, both upstream and downstream from the contractile proteins. Alternatively, it is possible that thin filament regulatory proteins are involved (Earley et al., 1998; Wang, 2001) . Although all thin filament proteins are present in the Triton X-100 permeabilized strips, kinases required for their regulation may not. 
Discussion
We have demonstrated in the present study that quinine inhibits histamine-induced contraction of isolated strips of swine carotid artery smooth muscle. This finding is consistent with previous reports describing the actions of quinine on rabbit and rat aorta (Cook et al., 1987; Del Pozo et al., 1996) . Quinine was earlier identified as a sympatholytic drug (Hiatt, 1950) exhibiting a higher degree of inhibition of the ␣ 1 -adrenoceptor compared with the ␣ 2 -adrenoceptor (Motulsky et al., 1984) . The results of our study do not rule out the possibility that quinine produces receptor blockade, but instead have extended the list of inhibitory effects of quinine on smooth muscle contractility to include intracellular sites.
Vascular smooth muscle can synthesize and release prostanoids that are capable of modulating the contractile response (Mombouli and Vanhoutte, 1999) . Bioactive prostanoids are derived from enzymatic activity downstream of cyclooxygenase. Inhibition of cyclooxygenase activity by indomethacin did not abolish the inhibitory effect of quinine on vascular smooth muscle. Thus, we were able to rule out the possibility that quinine-induced inhibition is mediated by either the activation of relaxing prostanoids or the inhibition jpet.aspetjournals.org of contractile prostanoids. A second relaxation pathway that could account for the effect of quinine is the NO/cGMP cascade. Endogenous NO and related nitrovasodilators regulate vascular smooth muscle contraction by activation of soluble guanylate cyclase, elevation of cGMP, and activation of cGMP-dependent protein kinase (Ignarro et al., 1999) . Cyclic GMP-mediated vascular smooth muscle cell relaxation is characterized by a reduction in intracellular calcium concentration (Lincoln et al., 2001) and by activation of the MLC phosphatase, which dephosphorylates phosphorylated MLC (Lee et al., 1997; Surks et al., 1999) . In addition, NO directly 
Fig. 4. Effect of quinine on Ca
2ϩ -induced contraction of ␣-toxin permeabilized vascular smooth muscle strips. Permeabilized strips were incubated in the absence (F) or presence (E) of 300 M quinine and then subjected to increasing [Ca 2ϩ ]. Quinine significantly depressed Ca 2ϩ -dependent force development in the ␣-toxin permeabilized arterial strips. Values shown are the means Ϯ S.E. for four to six determinations. stimulates Ca 2ϩ activated K ϩ channels in smooth muscle cells (Bolotina et al., 1994; Koh et al., 1995) , resulting in hyperpolarization, a decrease in Ca 2ϩ influx, and consequently muscle relaxation (Lincoln and Cornwell, 1991; Robertson et al., 1993; Mazzuco et al., 2000) . Thus, we examined the role played by cGMP-dependent mechanisms in quinineinduced relaxation of the artery. ODQ had no effect on quinine-induced relaxation of the arterial strips. This suggests that the quinine-induced relaxation in porcine carotid artery is not mediated through a cGMP-dependent pathway.
As stated above, an increase in intracellular Ca 2ϩ initiates smooth muscle cell contraction by activation of the calmodulin-dependent MLC kinase that catalyzes phosphorylation of the 20-kDa MLC. MLC phosphorylation activates the myosin molecule, allowing interaction with actin and the resultant active crossbridge cycling and development of force. In view of this, we determined whether inhibition of the contraction by quinine is related to the phosphorylation level of MLC. Our results demonstrate that quinine inhibits contraction without significantly affecting MLC phosphorylation levels, at the initial force development stage of contraction. This supports the hypothesis that quinine-induced decreases in contraction are not associated with changes at the level of the Ca 2ϩ /calmodulin complex or MLC kinase/phosphatase. This possibility is also supported by the finding that 600 M quinine completely abolished a histamine-induced contraction without significantly affecting MLC phosphorylation levels at the typical peak value at 1 min of stimulation. If MLC phosphatase activity was increased by quinine, MLC phosphorylation levels would be expected to be decreased. Our suggestion is again supported by the fact that quinine failed to inhibit Ca 2ϩ -induced contraction in Triton X-100 permeabilized strips, a preparation typically devoid of modulatory signaling pathways. Intact smooth muscle treated with quinine had lower steady-state levels of force and the timedependent decrease in MLC phosphorylation levels was more rapid in the presence of quinine. Although the decrease in maintained force was significantly greater than the decrease in MLC phosphorylation, the fact that MLC phosphorylation levels were lower suggests that in addition to any calciumindependent pathways affected by quinine, the Ca 2ϩ -dependent pathway may also be impaired or MLC phosphatase activity may be enhanced.
It is well known that the calcium sensitivity of smooth muscle contractile filaments can be modulated (Morgan and Morgan, 1984) . One of the primary models used to study this phenomenon has been the ␣-toxin permeabilized fiber. Smooth muscles permeabilized with ␣-toxin retain their responsiveness to agonist activation and maintain intracellular signaling pathways, while allowing control of the intracellular environment (Nishimura et al., 1988; Gong et al., 1996) . Quinine significantly inhibited Ca 2ϩ -dependent contractions of ␣-toxin permeabilized strips, whereas Ca 2ϩ -dependent contractions of the Triton X-100 permeabilized strips were unaffected. The primary difference between these two permeabilized preparations is the presence of modulatory pathways in the ␣-toxin preparation compared with the lack of these pathways in the Triton X-100 preparation. This information, coupled with the finding that quinine did not depress initial MLC phosphorylation levels supports the speculation that quinine does not inhibit contraction by alterations in the G protein-dependent change in myofilament calcium sensitivity but instead inhibits contraction downstream from the contractile apparatus.
Our results do not rule out the thin filaments as a site for quinine inhibition. It has been, in our opinion, clearly shown that thin filament proteins can regulate or at least modulate smooth muscle contraction (Earley et al., 1998; Wang 2001 ). The Triton X-100 permeabilized fibers contain physiological levels of thin filament proteins. However, they may or may not contain the components required for activation/inhibition of the thin filament regulatory proteins. This could account for the lack of effect of quinine in the detergent skinned fiber compared with the pronounced inhibition at constant calcium in the ␣-toxin permeabilized fiber.
One growing area of study on smooth muscle modulation is at the connection of the actin-and myosin-containing contractile lattice structure with the cell membrane. Gunst and collaborators have provided, over the years, compelling evidence suggesting that the mechanical transduction of the work performed by the crossbridges to the cell membrane may be modulated by proteins at the level of the focal adhesions (Pavalko et al., 1995; Wang et al., 1996) . Most notably, phosphorylation levels of the proteins talin and paxillin have been shown to change with mode of contractile stimulation. It is interesting to speculate that quinine may alter the pathways involved in talin and/or paxillin phosphorylation and thus change the coupling efficiency between the crossbridges and the focal adhesions on the cell membrane.
In summary, we have shown that quinine inhibits contraction of the swine carotid arterial smooth muscle. Our results suggest that the mechanism by which quinine inhibits contraction is not exclusively through a decrease in activator calcium concentrations. We have also shown that quinine does not inhibit contraction by stimulation of pathways in- -dependent contractions of ␣-toxin permeabilized and Triton X-100 skinned vascular strips. ␣-Toxin permeabilized and Triton X-100 skinned strips were incubated in the absence or presence of 300 M quinine and then stimulated with 0.7 M Ca 2ϩ . Quinine significantly depressed Ca 2ϩ -dependent contractions of ␣-toxin permeabilized preparations but had no effect on Ca 2ϩ -dependent contractions of the Triton X-100 skinned tissues. Values shown are the means Ϯ S.E. for four to six determinations.
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at ASPET Journals on April 19, 2017 jpet.aspetjournals.org volved in active relaxation, at least not through the prostaglandin or nitric oxide pathways. Instead, our results suggest that quinine-dependent inhibition of contraction involves a modulatory pathway present in the smooth muscle cell. Based in part on the fact that 1) quinine inhibited Ca 2ϩ -dependent contractions of the ␣-toxin permeabilized preparation, which retains modulatory pathways both upstream and downstream from the contractile proteins; 2) quinine did not inhibit the GTP␥S-induced contraction of the ␣-toxin permeabilized preparation important in upstream modulation of contraction; and 3) quinine did not inhibit MLC phosphorylation levels and force in the Triton X-100 permeabilized strips, which are devoid of all modulatory pathways; we suggest that a pathway(s) downstream from the contractile proteins is the site of quinine-dependent inhibition. Therefore, we propose the hypothesis that quinine decreases the coupling of the contractile filaments with the focal adhesions on the sarcolemma.
